NasdaqGS - Nasdaq Real Time Price USD

Verve Therapeutics, Inc. (VERV)

4.1600
-0.1900
(-4.37%)
At close: May 13 at 4:00:01 PM EDT
4.1990
+0.04
+(0.94%)
After hours: May 13 at 7:42:22 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
32,332
32,332
11,758
1,941
0
Operating Expense
260,992
260,992
234,882
167,628
87,067
Operating Income
-228,660
-228,660
-223,124
-165,687
-87,067
Net Non Operating Interest Income Expense
28,762
28,762
23,166
6,867
142
Other Income Expense
1,538
1,538
165
1,486
-33,389
Pretax Income
-198,360
-198,360
-199,793
-157,334
-120,314
Tax Provision
349
349
275
53
0
Net Income Common Stockholders
-198,709
-198,709
-200,068
-157,387
-120,314
Diluted NI Available to Com Stockholders
-198,709
-198,709
-200,068
-157,387
-120,314
Basic EPS
-2.35
--
-3.12
-2.91
-4.48
Diluted EPS
-2.35
--
-3.12
-2.91
-4.48
Basic Average Shares
84,722.2770
--
64,175.1370
54,023.6530
26,872.0360
Diluted Average Shares
84,722.2770
--
64,175.1370
54,023.6530
26,872.0360
Total Operating Income as Reported
-228,660
-228,660
-223,124
-165,687
-87,067
Total Expenses
260,992
260,992
234,882
167,628
87,067
Net Income from Continuing & Discontinued Operation
-198,709
-198,709
-200,068
-157,387
-120,314
Normalized Income
-198,709
-198,709
-200,068
-157,387
-120,314
Net Interest Income
28,762
28,762
23,166
6,867
142
EBIT
-228,660
-228,660
-223,124
-165,687
-87,067
EBITDA
-221,907
-221,907
-217,669
-162,883
-85,532
Reconciled Depreciation
6,753
6,753
5,455
2,804
1,535
Net Income from Continuing Operation Net Minority Interest
-198,709
-198,709
-200,068
-157,387
-120,314
Normalized EBITDA
-221,907
-221,907
-217,669
-162,883
-85,532
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 6/17/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

BEAM Beam Therapeutics Inc.
18.05
-1.04%
 
CRBU Caribou Biosciences, Inc.
0.7828
-4.31%
 
PRME Prime Medicine, Inc.
1.2700
-5.22%
 
NTLA Intellia Therapeutics, Inc.
8.32
-2.69%
 
SANA Sana Biotechnology, Inc.
1.7950
-10.25%
 
FATE Fate Therapeutics, Inc.
1.0000
-6.54%
 
EDIT Editas Medicine, Inc.
1.5000
-2.60%
 
ALLO Allogene Therapeutics, Inc.
1.1300
-3.42%
 
VOR Vor Biopharma Inc.
0.1600
-7.25%
 
SGMO Sangamo Therapeutics, Inc.
0.4600
-38.40%